Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

1.84
Delayed Data
As of Dec 09
 -0.05 / -2.65%
Today’s Change
1.51
Today|||52-Week Range
14.10
-86.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues18.0M19.7M7.4M7.7M
 
 
 
 
 
Depreciation And Amortization1.3M1.4M1.5M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses45.0M45.9M45.3M40.8M
 
 
 
 
 
Research And Development38.2M36.1M37.5M32.9M
 
 
 
 
 
Total Operating Expenses46.3M47.3M46.8M42.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.2M-27.6M-39.4M-34.7M
 
 
 
 
 
Extraordinary Charge0.000.000.00-4.1M
 
 
Interest Expense On Debt5.1M5.0M--6.2M
 
 
 
 
Other Expenses-4.0K551.0K-5.4M129.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.2M-31.9M-44.8M-44.7M
 
 
 
 
 
Net Income-33.2M-31.9M-44.8M-44.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.0M87.0M87.1M87.1M
 
 
 
 
 
Shares To Calculate EPS Diluted87.0M87.0M87.1M87.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.37-$0.51-$0.51
 
 
 
 
 
EPS Diluted-$0.38-$0.37-$0.51-$0.51